MUC1

Product Inquiry

MUC1 Background

MUC1恶性肿瘤细胞中,MUC1则以糖基脱落的形式特异性地过表达于多种癌细胞表面,从而减少细胞之间和细胞外基质(ECM)之间的相互作用,促进肿瘤转移。MUC1已被证实在多种实体瘤的上皮细胞中高表达,包括肺癌、乳腺癌、胃癌、卵巢癌和结直肠癌等。其广泛的肿瘤相关表达特征,使MUC1不仅成为多种实体瘤的重要生物标志物,也成为ADC、抗体药物及细胞疗法等新型治疗手段重点关注的靶点。

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Bomtabegagene bavoparvovecAAV9-GLB1; AXO-AAV-GM1Phase 2 ClinicalUniversity Of Massachusetts Medical SchoolGangliosidoses
Details
  • Product Inquiry
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland